Kevin Anderson - Concepedia

Author

Kevin Anderson

Ionis Pharmaceuticals (United States)ORCID

Also Known As

Jonna A. K. Mazet, K Anderson, K P Anderson, K. Anderson, K.P. Anderson, KEVIN P. ANDERSON, Kevin Anderson, Kevin P. Anderson

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Ionis Pharmaceuticals (United States)United States Army Medical Research Institute of Infectious Diseases University of Alabama at Birmingham University of California, Irvine National Institutes of Health

About

Kevin Anderson is an author at Ionis Pharmaceuticals (United States) specializing in virology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	37	2.8K
2	Natural Sciences	16	16	1.1K
3	Allergy	3	3	168
4	Engineering	2	2	70
5	Health Sciences	1	1	79

Kevin Anderson

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Evaluation in Nonhuman Primates of Vaccines against Ebola Virus Thomas W. Geisbert, Peter Pushko, Kevin Anderson, Emerging infectious diseases	2002	241
Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus E. J. Stott, Geraldine Taylor, L. Andrew Ball, Journal of Virology VaccinationVaccinologyMucosal VaccinationVeterinary VaccineVaccine Development	1987	215
Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region Rumana Azad, Vickie B. Driver, Keiko Tanaka, Antimicrobial Agents and Chemotherapy Viral ReplicationMolecular VirologyIe Protein SynthesisAntiviral ActivityMedicine	1993	205
Inhibition of human cytomegalovirus immediate-early gene expression by an antisense oligonucleotide complementary to immediate-early RNA Kevin Anderson, Maureen Fox, Vickie Brown‐Driver, Antimicrobial Agents and Chemotherapy Viral ReplicationImmunologyMolecular BiologyImmunotherapyImmediate-early Rna	1996	154
The herpes simplex virus latency-associated transcript is spliced during the latent phase of infection E K Wagner, W. Michael Flanagan, G B Devi-Rao, Journal of Virology Viral ReplicationLatency-associated TranscriptGeneticsViral PersistenceSpliced Species	1988	152
Viral DNA synthesis is required for the efficient expression of specific herpes simplex virus type 1 mRNA species L E Holland, Kevin Anderson, Charles Shipman, Virology Viral ReplicationMolecular VirologyEfficient ExpressionNatural SciencesImmunology	1980	150
Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus A.H Cherrie, Kevin Anderson, Gail W. Wertz, Journal of Virology VaccinationNormal AdultsViral ReplicationMolecular VirologyMedicine	1992	138
Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice Gail W. Wertz, E. J. Stott, K K Young, Journal of Virology Viral ReplicationViral PathogenesisImmunologyMolecular BiologyVaccinated Mice	1987	134
Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes Ronnie Hanecak, Vickie Brown‐Driver, Maureen Fox, Journal of Virology Transformed HepatocytesHcv 5Viral ReplicationImmunologyPathology	1996	122
Complete Nucleotide Sequences of the M and S Segments of Two Hantavirus Isolates from California: Evidence for Reassortment in Nature among Viruses Related to Hantavirus Pulmonary Syndrome Dexin Li, Alan Schmaljohn, Kevin Anderson, Virology Hantavirus IsolatesS SegmentsHantavirus Pulmonary SyndromeViral EvolutionPathogenesis	1995	120

Page 1